Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) EBT (2016 - 2025)

INVO Fertility (IVF) has disclosed EBT for 15 consecutive years, with -$2.6 million as the latest value for Q3 2025.

  • Quarterly EBT fell 65.14% to -$2.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$26.9 million through Sep 2025, down 263.35% year-over-year, with the annual reading at -$9.1 million for FY2024, 13.89% down from the prior year.
  • EBT for Q3 2025 was -$2.6 million at INVO Fertility, up from -$3.2 million in the prior quarter.
  • The five-year high for EBT was $101782.0 in Q4 2021, with the low at -$17.4 million in Q1 2025.
  • Average EBT over 5 years is -$3.0 million, with a median of -$2.5 million recorded in 2021.
  • The sharpest move saw EBT soared 102.67% in 2021, then tumbled 2816.55% in 2022.
  • Over 5 years, EBT stood at $101782.0 in 2021, then crashed by 2816.55% to -$2.8 million in 2022, then rose by 28.69% to -$2.0 million in 2023, then plummeted by 86.51% to -$3.7 million in 2024, then increased by 28.09% to -$2.6 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$2.6 million, -$3.2 million, and -$17.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.